Aera Therapeutics

BiotechnologySeries BBoston, USaeratx.com

Latest round

Series B

Last raised

Feb 2023

Total raised

Undisclosed

Investors

3

About Aera Therapeutics

Based in Boston, US, and founded in 2021 by Akin Akinc (CEO), John Maraganore, Robert Nelsen, Issi Rozen, Vicki Sato, David Schenkein, and Josh Wolfe, Aera Therapeutics Inc. is a biotechnology company that uses its proprietary technology to help deliver genetic medicines to various tissues and applications, thereby benefiting more patients across a wider range of disease areas. Aera Therapeutics Inc. is a biotechnology company that uses its proprietary technology to help deliver genetic medicines to various tissues and applications, thereby benefiting more patients across a wider range of disease areas. In February 2023, Aera Therapeutics Inc. The company uses its proprietary protein nanoparticle (PNP) delivery platform, which leverages the discovery of endogenous, human proteins that can self-assemble into capsid-like structures and package and transfer nucleic acid cargo to enable various genetic medicine modalities. Moreover, the firm also offers a proprietary therapeutic enzyme platform based on the discovery of novel, compact, and programmable gene-editing enzymes.

Who invested in Aera Therapeutics

3 investors across 2 rounds

See all investors in Aera Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Feb 16, 2023

    Amount

    Undisclosed

    Investors

    Locked

  2. Series A

    Oct 22, 2022

    Amount

    Undisclosed

    Investors

    Locked

Questions about Aera Therapeutics

Who invested in Aera Therapeutics?

Aera Therapeutics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Aera Therapeutics raised?

Aera Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Aera Therapeutics last raise money?

Aera Therapeutics's most recent round on record is a Series B, in Feb 2023.

What does Aera Therapeutics do?

Based in Boston, US, and founded in 2021 by Akin Akinc (CEO), John Maraganore, Robert Nelsen, Issi Rozen, Vicki Sato, David Schenkein, and Josh Wolfe, Aera Therapeutics Inc.

Where is Aera Therapeutics headquartered?

Aera Therapeutics is headquartered in Boston, US.

Which VCs invest in companies like Aera Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aera Therapeutics's stage. Their profiles are linked below.

Raising like Aera Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.